SitesBLAST
Comparing PfGW456L13_3476 FitnessBrowser__pseudo13_GW456_L13:PfGW456L13_3476 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 13 hits to proteins with known functional sites (download)
P0AA76 D-galactonate transporter; D-galactonate/H(+) symporter from Escherichia coli (strain K12) (see paper)
41% identity, 92% coverage: 33:460/467 of query aligns to 9:428/430 of P0AA76
- Y29 (≠ T53) binding
- D31 (= D55) mutation to N: Loss of galactonate transport activity.
- R32 (= R56) binding
- Y64 (= Y88) binding
- E118 (= E146) mutation to Q: Loss of galactonate transport activity.
- W358 (= W389) binding
6e9nA E. Coli d-galactonate:proton symporter in the inward open form (see paper)
42% identity, 91% coverage: 38:460/467 of query aligns to 3:409/409 of 6e9nA
6e9oA E. Coli d-galactonate:proton symporter mutant e133q in the outward substrate-bound form (see paper)
39% identity, 92% coverage: 33:460/467 of query aligns to 1:393/393 of 6e9oA
Q9JI12 Vesicular glutamate transporter 2; VGluT2; Differentiation-associated BNPI; Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter; Solute carrier family 17 member 6 from Rattus norvegicus (Rat) (see 2 papers)
26% identity, 83% coverage: 38:424/467 of query aligns to 70:465/582 of Q9JI12
- R88 (= R56) mutation to A: Impairs synaptic transmission. Abolishes the chloride ion conductance.
- H128 (≠ F81) mutation to A: Greatly lowers L-glutamate transport.
- R184 (= R139) mutation R->A,E,K: Greatly lowers L-glutamate transport.
- E191 (= E146) mutation to A: Greatly lowers L-glutamate transport.; mutation E->D,Q: Lowers L-glutamate transport.
- R322 (≠ I283) mutation to A: Loss of L-glutamate release. Abolishes the chloride ion conductance.
Q8BN82 Sialin; H(+)/nitrate cotransporter; H(+)/sialic acid cotransporter; AST; Solute carrier family 17 member 5; Vesicular excitatory amino acid transporter; VEAT from Mus musculus (Mouse) (see paper)
26% identity, 78% coverage: 57:422/467 of query aligns to 88:443/495 of Q8BN82
- H183 (≠ G154) mutation to R: Abolishes sialic acid transporter activity. Does not affect L-aspartate and L-glutamate transporter activity.
Sites not aligning to the query:
- 39 R→C: Completely abolishes L-aspartate and L-glutamate transporter activity. Retains appreciable H(+)-coupled sialic acid transporter activity.
Q9NRA2 Sialin; H(+)/nitrate cotransporter; H(+)/sialic acid cotransporter; AST; Membrane glycoprotein HP59; Solute carrier family 17 member 5; Vesicular excitatory amino acid transporter; VEAT from Homo sapiens (Human) (see 8 papers)
26% identity, 78% coverage: 57:422/467 of query aligns to 88:443/495 of Q9NRA2
- K136 (= K105) to E: in SD; alters intracellular localization, only partially targeted to lysosomes and mainly detected in LAMP1-negative vesicles and in the Golgi apparatus; completely devoid of L-aspartate and L-glutamate transporter activity, but retains appreciable H(+)-coupled sialic acid transporter activity; dbSNP:rs80338795
- H183 (≠ G154) to R: in ISSD; alters intracellular localization, only partially targeted to lysosomes and mainly detected in LAMP1-negative vesicles and in the Golgi apparatus; abolishes H(+)-coupled sialic acid transporter activity; has normal L-aspartate and L-glutamate transporter activity; dbSNP:rs119491109
- LL 198:199 (≠ AG 169:170) mutation to AA: Localizes in vesicular structures mainly concentrated in the perinuclear region.
- I--------L 266:267 (≠ IRAGDGLVDL 236:245) mutation to LA: Localizes in vesicular structures mainly concentrated in the perinuclear region.
- SSLRN 268:272 (≠ ESLKS 246:250) natural variant: Missing (in ISSD; alters intracellular localization, only partially targeted to lysosomes and mainly detected in LAMP1-negative vesicles and in the Golgi apparatus; abolishes H(+)-coupled sialic acid transporter activity; has normal L-aspartate and L-glutamate transporter activity)
- G328 (= G310) to E: in ISSD; some patients may manifest a milder phenotype consistent with Salla disease; markedly decreases H(+)-coupled sialic acid transporter activity; abolishes L-aspartate and L-glutamate transporter activity; dbSNP:rs386833996
- P334 (= P316) to R: in ISSD; does not affect intracellular localization, targeted to lysosomes; abolishes H(+)-coupled sialic acid transporter activity; abolishes L-aspartate and L-glutamate transporter activity; dbSNP:rs119491110
- G371 (= G352) to V: in ISSD; abolishes H(+)-coupled sialic acid transporter activity; abolishes L-aspartate and L-glutamate transporter activity; dbSNP:rs777862172
Sites not aligning to the query:
- 22:23 Dileucine internalization motif; LL→AA: Targeted to plasma membrane.; LL→GG: Targeted to plasma membrane; sialic acid uptake strongly activated at acidic pH.
- 39 R → C: in SD; frequent variant in Finland; alters intracellular localization, only partially targeted to lysosomes and mainly detected in LAMP1-negative vesicles and in the Golgi apparatus; completely devoid of L-aspartate and L-glutamate transport activity, but retains appreciable H(+)-coupled sialic acid and nitrate transporter activity; dbSNP:rs80338794
7t3nA R184q/e191q mutant of rat vesicular glutamate transporter 2 (vglut2)
25% identity, 83% coverage: 38:424/467 of query aligns to 12:407/452 of 7t3nA
- binding (1s,3r)-1-aminocyclopentane-1,3-dicarboxylic acid: Y77 (= Y88), Y137 (≠ G150), Y165 (= Y178), R264 (≠ I283), F268 (≠ T287), Y269 (≠ W288)
- binding (2R)-2-(methoxymethyl)-4-{[(25R)-spirost-5-en-3beta-yl]oxy}butyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside: R12 (= R38), Y13 (≠ F39), E152 (= E165), G163 (≠ A176)
Q5Q0U0 Sialin; H(+)/nitrate cotransporter; H(+)/sialic acid cotransporter; AST; Solute carrier family 17 (Anion/sugar transporter), member 5; Vesicular excitatory amino acid transporter; VEAT from Rattus norvegicus (Rat) (see 2 papers)
26% identity, 78% coverage: 57:422/467 of query aligns to 88:443/495 of Q5Q0U0
- K136 (= K105) mutation to E: Markedly decreases H(+)-coupled sialic acid transporter activity.
- R168 (= R139) mutation to C: Abolishes H(+)-coupled sialic acid transporter activity.
- E171 (≠ L142) mutation to C: Decreases H(+)-coupled sialic acid transporter activity; when associated with C-175.
- G172 (= G143) mutation to C: Decreases protein levels and alters subcellular localization.
- E175 (= E146) mutation to C: Decreases H(+)-coupled sialic acid transporter activity; when associated with C-171.
- G176 (≠ S147) mutation to C: Decreases protein levels and alters subcellular localization.
- F179 (≠ G150) mutation to C: Decreases the affinity and transport rate for D-glucuronate. Does not affect H(+)-coupled sialic acid transporter activity.
- P180 (= P151) mutation to C: Decreases protein levels and alters subcellular localization.
- H183 (≠ G154) mutation to R: Abolishes H(+)-coupled sialic acid transporter activity.
- W186 (≠ I157) mutation to C: Abolishes H(+)-coupled sialic acid transporter activity.
- SSLKN 268:272 (≠ ESLKS 246:250) mutation Missing: Abolishes H(+)-coupled sialic acid transporter activity.
- P334 (= P316) mutation to R: Abolishes H(+)-coupled sialic acid transporter activity.
- G371 (= G352) mutation to V: Remains in the endoplasmic reticulum.
Sites not aligning to the query:
- 22:23 Dileucine internalization motif; LL→AA: Targeted to plasma membrane; sialic acid uptake strongly activated at acidic pH.
- 39 R→C: Markedly decreases H(+)-coupled sialic acid transporter activity.
Q9Y2C5 Probable small intestine urate exporter; Solute carrier family 17 member 4 from Homo sapiens (Human) (see 2 papers)
26% identity, 76% coverage: 77:433/467 of query aligns to 110:457/497 of Q9Y2C5
- A372 (≠ T350) to T: in dbSNP:rs11754288
Sites not aligning to the query:
- 66 modified: carbohydrate, N-linked (GlcNAc...) asparagine; N→A: Loss of glycosylation and significant reduction in the tranport of thyroid hormones T3 and T4; when associated with A-75 and A-90.
- 75 modified: carbohydrate, N-linked (GlcNAc...) asparagine; N→A: Loss of glycosylation and significant reduction in the tranport of thyroid hormones T3 and T4; when associated with A-66 and A-90.
- 90 modified: carbohydrate, N-linked (GlcNAc...) asparagine; N→A: Loss of glycosylation and significant reduction in the tranport of thyroid hormones T3 and T4; when associated with A-75 and A-90.
Q03567 Uncharacterized transporter slc-17.2 from Caenorhabditis elegans (see paper)
21% identity, 75% coverage: 78:426/467 of query aligns to 84:430/493 of Q03567
Sites not aligning to the query:
- 69 modified: carbohydrate, N-linked (GlcNAc...) asparagine
O60669 Monocarboxylate transporter 2; MCT 2; Solute carrier family 16 member 7 from Homo sapiens (Human) (see paper)
23% identity, 80% coverage: 95:466/467 of query aligns to 76:434/478 of O60669
- R143 (= R166) mutation to A: Reduces pyruvate transmembrane transporter activity. Reduces pyruvate transmembrane transporter activity. No effect on protein abundance. Does not affect cell surface localization. Dominant negative mutant.
- N147 (≠ G170) mutation to A: Reduces pyruvate transmembrane transporter activity. Reduces pyruvate transmembrane transporter activity. No effect on protein abundance. Does not affect cell surface localization.
- F262 (= F289) mutation to A: No effect on protein abundance. Does not affect cell surface localization.
- D293 (≠ G320) May be protonated during monocarboxylate transport; mutation to N: Reduced proton-dependent active symport, but not pyruvate transport.
- R297 (≠ G324) mutation R->L,D: Reduces pyruvate transmembrane transporter activity. No effect on protein abundance. Does not affect cell surface localization.
- N305 (≠ D332) mutation to A: Reduces pyruvate transmembrane transporter activity. No effect on protein abundance. Does not affect cell surface localization.
- F351 (= F384) mutation to A: Reduces pyruvate transmembrane transporter activity. No effect on protein abundance. Does not affect cell surface localization.
- S355 (≠ G388) mutation S->G,A: Reduces pyruvate transmembrane transporter activity. No effect on protein abundance. Does not affect cell surface localization.
- E360 (≠ D394) mutation to A: Reduces pyruvate transmembrane transporter activity. No effect on protein abundance. Does not affect cell surface localization.
Sites not aligning to the query:
- 18 W→A: Reduces pyruvate transmembrane transporter activity. No effect on protein abundance. Does not affect cell surface localization. Dominant negative mutant.
- 20 W→A: Reduces pyruvate transmembrane transporter activity. No effect on protein abundance. Does not affect cell surface localization. Dominant negative mutant.
- 34 Y→F: Reduces pyruvate transmembrane transporter activity. No effect on protein abundance. Does not affect cell surface localization.
- 38 K→D: Reduces pyruvate transmembrane transporter activity. No effect on protein abundance. Does not affect cell surface localization.
- 70 Y→A: No effect on protein abundance. Does not affect cell surface localization.
- 445 T → S: in dbSNP:rs3763980
Q5EXK5 3-hydroxybenzoate transporter MhbT from Klebsiella oxytoca (see paper)
22% identity, 87% coverage: 29:434/467 of query aligns to 13:410/452 of Q5EXK5